Results 31 to 40 of about 3,790 (190)

COMPARISON OF HYDRALAZINE AND LABETALOL IN THE MANAGEMENT OF HYPERTENSIVE DISORDERS OF PREGNANCY

Pakistan Armed Forces Medical Journal, 2022
Objective: To compare the efficacy of intravenous hydralazine and intravenous labetalol for acutely lowering blood pressure in pregnancy. Study Design: Randomized control trial (RCT).
Humaira Osman Jaffery, Kausar Tasleem Bangash   +1 more
doaj   +2 more sources

Intravenous labetalol in the treatment of severe hypertension. [PDF]

British Journal of Clinical Pharmacology, 1982
1 We have compared, in patients with severe hypertension, the administration of intravenous labetalol by single rapid injection, by repeated bolus injections, and by incremental infusion. 2 Incremental infusion was the most consistently (albeit not invariably) effective method, and that least prone to cause side‐effects.
A M, Cumming, J J, Brown, A F, Lever, J I, Robertson   +3 more
openaire   +2 more sources

Different dosage regimens of nifedipine, labetalol, and hydralazine for the treatment of severe hypertension during pregnancy: a network meta-analysis of randomized controlled trials

Hypertension in Pregnancy, 2022
Objectives This network meta-analysis aimed to compare the efficacy and safety of intravenous (IV) hydralazine, oral nifedipine, and IV labetalol with different dosage regimens in the treatment of severe hypertension during pregnancy.
Hui-Zhen Wu, Yuan Cheng, Ding Yu, Ji-Bin Li, Yun-Fa Jiang, Zhong-Ning Zhu   +5 more
doaj   +1 more source

Labetalol Pretreatment Reduces Blood Pressure Instability During Surgical Resection of Pheochromocytoma

Journal of the Formosan Medical Association, 2006
To evaluate the effect of pretreatment with the mixed alpha- and beta-adrenergic blocker, labetalol, on blood pressure instability during surgical resection of pheochromocytoma. Methods: Blood pressure stability and surgical results were compared between
Peter Chi-Ho Chung, Yuet-Tong Ng, Jing-Ru Hsieh, Min-Wen Yang, Allen Hon-Lun Li   +4 more
doaj   +1 more source

Development and Evaluation of a Physiologically Based Pharmacokinetic Model of Labetalol in Healthy and Diseased Populations

Pharmaceutics, 2022
Labetalol is a drug that exhibits both alpha and beta-adrenergic receptor-blocking properties. The American Heart Association/American Stroke Association (AHA/ASA) has recommended labetalol as an initial treatment option for the management of severe ...
Hafsa Hafsa, Ammara Zamir, Muhammad Fawad Rasool, Imran Imran, Hamid Saeed, Tanveer Ahmad, Sary Alsanea, Ali A. Alshamrani, Abdullah H. Alruwaili, Faleh Alqahtani   +9 more
doaj   +1 more source

The hemodynamic effects of intravenous labetalol for postoperative hypertension

Cleveland Clinic Journal of Medicine, 1989
Hemodynamic data were analyzed from 25 courses of intravenous pulse labetalol therapy for postoperative hypertension in 12 patients after major vascular surgeries. The hemodynamic determinations were obtained an average of 15 minutes after a therapeutic total dose of 10-120 mg of labetalol (mean, 37.5 mg).
J P, Orlowski, D G, Vidt, S, Walker, J F, Haluska   +3 more
openaire   +2 more sources

EFFICACY OF HYDRALAZINE IN COMPARISON WITH LABETALOL FOR CONTROL OF SEVERE HYPERTENSION IN PATIENTS WITH ECLAMPSIA

Pakistan Armed Forces Medical Journal, 2020
Objective: To compare the efficacy of intravenous hydralazine with intravenous labetalol for control of severe hypertension in eclamptic patients. Study Design: Cross-sectional study. Place and Duration of Study: Obstetrics and Gynecology unit “B”,
Mehwish Syed, Rizwan Faisal, Laiyla Shinwari, Afrah Aman, Rabia Nawaz, Sumayya   +5 more
doaj   +4 more sources

Regional Differences in Early BP Management After Acute Ischemic Stroke in the ENCHANTED International Randomized Controlled Trials

Frontiers in Neurology, 2021
Background and Aims: Epidemiological studies show significant variations in hypertension management within and between countries. The level of regional variation in early blood pressure (BP) management after acute stroke is uncertain.Methods: Data are ...
Chen Chen, Chen Chen, Chen Chen, Lili Song, Lili Song, Jie Yang, Richard Lindley, Richard Lindley, Thompson Robinson, Hisatomi Arima, John Chalmers, Craig S. Anderson, Craig S. Anderson, Craig S. Anderson, Xia Wang   +14 more
doaj   +1 more source

Unrecognised pheochromocytoma in pregnancy discovered through metoclopramide-triggered hypertensive emergency

Blood Pressure, 2021
Purpose Pheochromocytoma, a catecholamine-secreting tumour leading to neurological and cardiovascular life-threatening conditions through hypertension crisis, occurs in 0.1-0.5% of hypertensive patients, but it is extremely rare in pregnancy (0.0018-0 ...
Aurelio Negro, Ignazio Verzicco, Stefano Tedeschi, Rosaria Santi, Barbara Palladini, Anna Calvi, Alessandro Giunta, Davide Cunzi, Pietro Coghi, Riccardo Volpi, Aderville Cabassi   +10 more
doaj   +1 more source

The Ethical Cost of Delay: Lessons From an Acute Haemorrhagic Neurological Emergency in a Low‐Resource Setting

Clinical Case Reports, Volume 14, Issue 7, July 2026.
ABSTRACT Prompt recognition and early intervention are critical in the management of intracerebral hemorrhage. This case demonstrates how system‐level diagnostic and referral delays in a low‐resource setting can worsen outcomes, underscoring the ethical imperative for coordinated emergency pathways and equitable access to neurosurgical care.
Kwasi Asare Boadi, Dennis Awedam Achio, Eunice Wilberforce A. Achio   +2 more
wiley   +1 more source